Menu Search
Equities

Seikagaku Corp

4548:TYO

Seikagaku Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)836.00
  • Today's Change17.00 / 2.08%
  • Shares traded136.50k
  • 1 Year change+2.08%
  • Beta0.6174
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income1,6913,0695,395
Depreciation/depletion1,4821,151870
Non-Cash items(1149)(904)(818)
Cash taxes paid, supplemental525927158
Cash interest paid, supplemental4.005.0011
Changes in working capital(1691)(1918)2,564
Total cash from operations5141,5748,191
INVESTING
Capital expenditures(4560)(2052)(2050)
Other investing and cash flow items, total(2649)5,4172,920
Total cash from investing(7209)3,365870
FINANCING
Financing cash flow items0(141)(170)
Total cash dividends paid(1418)(1560)(1633)
Issuance (retirement) of stock, net0(1500)(221)
Issuance (retirement) of debt, net(43)(43)(127)
Total cash from financing(1461)(3244)(2151)
NET CHANGE IN CASH
Foreign exchange effects1,060735689
Net change in cash(7096)2,4307,599
Net cash-begin balance/reserved for future use25,79823,36715,767
Net cash-end balance/reserved for future use18,70125,79823,367
SUPPLEMENTAL INCOME
Depreciation, supplemental1,4821,151870
Cash interest paid, supplemental4.005.0011
Cash taxes paid, supplemental525927158
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.